This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Mon, 10/21/2024 - 15:52 Earlier this year, Materialise, a global supplier of 3D printing software and services, acquired FEops , a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions.
The comprehensive curriculum, meticulously crafted by industry experts, featured enlightening lectures, hands-on sessions with cutting-edge device, and an anatomy workshop that provided doctors with bull hearts and specialized tools. Behind every success story, there are dedicated mentors and instructors.
The comprehensive curriculum, meticulously crafted by industry experts, featured enlightening lectures, hands-on sessions with cutting-edge device, and an anatomy workshop that provided doctors with bull hearts and specialized tools. Behind every success story, there are dedicated mentors and instructors.
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heartvalve, for which more than 1.6 The imaging sub-study was a novel assessment of the right side of the heart using cardiac CT and MRI before and after a tricuspid repair procedure. Abbott has announced U.S
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Anatomy 
52 
Let's personalize your content